PALBOCICLIB CAPSULES

Clinical safety rating: avoid

Strong CYP3A4 inhibitors may increase levels Can cause severe neutropenia and pulmonary embolism.

How it works

Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.

Capsule 125 mg - Oral

Dosage form	CAPSULE
Renal impairment	Consult protocols for adjustment.
Liver impairment	Consult protocols for adjustment.

Clinical note

Strong CYP3A4 inhibitors may increase levels Can cause severe neutropenia and pulmonary embolism.

FDA category

Category Contraindicated

fatigue

Loading safety data…

Clinical safety rating: avoid

Strong CYP3A4 inhibitors may increase levels Can cause severe neutropenia and pulmonary embolism.

Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.

Capsule 125 mg - Oral

Dosage form	CAPSULE
Renal impairment	Consult protocols for adjustment.
Liver impairment	Consult protocols for adjustment.

Clinical note

Strong CYP3A4 inhibitors may increase levels Can cause severe neutropenia and pulmonary embolism.

FDA category

Category Contraindicated

fatigue

Loading safety data…